These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23484444)

  • 1. Re-overcoming barriers in translating biomarkers to clinical practice.
    Staratschek-Jox A; Schultze JL
    Expert Opin Med Diagn; 2010 Mar; 4(2):103-12. PubMed ID: 23484444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-based peptide, genetic, and epigenetic biomarkers for diagnosing gastrointestinal cancers.
    Kraus S; Goel A; Arber N
    Expert Opin Med Diagn; 2010 Nov; 4(6):459-71. PubMed ID: 23496227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What does systems biology mean for biomarker discovery?
    Azuaje F
    Expert Opin Med Diagn; 2010 Jan; 4(1):1-10. PubMed ID: 23496106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology].
    Ludwig WD
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):11-22. PubMed ID: 22325103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The national biomarker development alliance: confronting the poor productivity of biomarker research and development.
    Poste G; Compton CC; Barker AD
    Expert Rev Mol Diagn; 2015 Feb; 15(2):211-8. PubMed ID: 25420639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of in vitro and in vivo models of oesophageal and gastric cancer.
    Mukherji D; Benepal T
    Expert Opin Drug Discov; 2009 Dec; 4(12):1267-79. PubMed ID: 23480466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New biomarkers for lung cancer.
    Paci M; Rapicetta C; Maramotti S
    Expert Opin Med Diagn; 2010 May; 4(3):201-24. PubMed ID: 23488531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 1: acute and monophasic diseases.
    Kuhle J; Petzold A
    Expert Opin Med Diagn; 2011 Jul; 5(4):333-46. PubMed ID: 23484553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary biomarkers for periodontal disease diagnostics.
    Brinkmann O; Zhang L; Giannobile WV; Wong DT
    Expert Opin Med Diagn; 2011 Jan; 5(1):25-35. PubMed ID: 23484474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide association studies for the identification of biomarkers in metabolic diseases.
    Pattin KA; Moore JH
    Expert Opin Med Diagn; 2010 Jan; 4(1):39-51. PubMed ID: 23496109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New clinical molecular diagnostic methods for congenital and inherited heart disease.
    Jongbloed JD; Pósafalvi A; Kerstjens-Frederikse WS; Sinke RJ; van Tintelen JP
    Expert Opin Med Diagn; 2011 Jan; 5(1):9-24. PubMed ID: 23484473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptance of biomarker-based tests for application in clinical practice: criteria and obstacles.
    Pirmohamed M
    Clin Pharmacol Ther; 2010 Dec; 88(6):862-6. PubMed ID: 20981006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational systems approach for drug target discovery.
    Chandra N
    Expert Opin Drug Discov; 2009 Dec; 4(12):1221-36. PubMed ID: 23480463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.
    Flynn MA; McNeil DA; Maloff B; Mutasingwa D; Wu M; Ford C; Tough SC
    Obes Rev; 2006 Feb; 7 Suppl 1():7-66. PubMed ID: 16371076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translation of neurological biomarkers to clinically relevant platforms.
    Hayes RL; Robinson G; Muller U; Wang KK
    Methods Mol Biol; 2009; 566():303-13. PubMed ID: 20058180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community acquired bacterial pneumonia.
    Anevlavis S; Bouros D
    Expert Opin Pharmacother; 2010 Feb; 11(3):361-74. PubMed ID: 20085502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.